Secondary analysis of 87 PROMOTE trial participants with painful knee osteoarthritis: on methotrexate, IL-8 and TNF-α fell and IL-15 rose; higher baseline IFN-γ and falling TNF-α were linked to greater pain reduction. Only hs-CRP showed consistent treatment-by-marker effects.
Secondary analysisn = 87
Liang et al. Systemic biomarkers of treatment response to methotrexate in people with painful knee osteoarthritis: A biological substudy of the PROMOTE randomised controlled clinical trial